ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000382.1|Lipstatin_1 # 456 # 1580 # 1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.713	BGC0000382.1|Lipstatin_1 	456	1580	+	Loose	200	27.7202	Pseudomonas aeruginosa soxR	26.17	3004107	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGTACCACCGAGCGCCGCAGCCGAATAGAGGCCCTCGGCGCCTTTCTTCCCGCGGGACGCGAGACCAACGACGAACTCCGCGCGAAGGTGCCGAACCTGGGTGACGCGGACGTCCGCCGGATCACCGGCATCGCCGAGCGCCGCGTCCACGACCCCGACCCGGCCGCCGGCGAGGACTCCTTCGGGATGGCCCTCGCCGCAGCCCGCGACTGCCTGGCCGTCTCCCGCCACCGGGCGGCCGACCTCGACGTCGTCATCAGCGCGTCCATCACCCGCGTGAAGGACGGCAGCCGCTTCCACTTCGAGCCGTCCTTCGCCGGAATGCTGGCCAAGGAGCTGGGCGCCCGGCCCGCCATCAGCTTCGACGTCTCCAACGCCTGCGCCGGCATGATGACCGGCGTGTGGCTGCTGGACCGGATGATCCGCTCCGGCGCCGTCCGCAGCGGCATGGTCGTCAGCGGCGAGCAGGCCACCCGCGTCGCCCGCACCGCCGCCCGCGAACTGCGCGACTCCTACGACCCGCAGTTCGCCTCCCTCTCGGTCGGCGACTCCGCCGCCGCGGTCGTCCTCGACGAATCCACCGACCCCGCCGACCGCATCCACTACATCGAGCTCATGACCTGCGCCGCATACTCCCACCTGTGCCTGGGAATGCCGAGCGACCGCAGCCAGGGAATCGGCCTCTACACCGACAACAAGAAGATGCACGACCGGGAACGCCTCAAACTGTGGCCGCGGTTCCACGAGGATTTCCTCGCCAAGAACGGGCGCCGTTTCGAGGACGAGGAATTCGACCACATCATTCAACACCAGGTCGGCACCCGGTTCATCGAGTACGCCAACCGGACCGCCGAGGCCGAGTTCGCCGCGCCCATGCCGCCGTCCCTCCAGGTCGTGGAACAGTACGGCAACACCGCCACCACCTCCCACTTCCTGACCCTGCGCGACCACCTCCGCCGCACCCGCGGCGCGGGAGCCACCGGCACCGGTACAGGCCCCGGGTCCGGCCCCGGCGCCGGCCCGGCGCGGGAGGCCGCGGGCGCCAAGTACCTCCTGGTGCCCGCCGCCTCCGGCCTCGTCACCGGCGCGCTGTCCGCAACCGTCACCCACGCAGGGGCCTGA	MSTTERRSRIEALGAFLPAGRETNDELRAKVPNLGDADVRRITGIAERRVHDPDPAAGEDSFGMALAAARDCLAVSRHRAADLDVVISASITRVKDGSRFHFEPSFAGMLAKELGARPAISFDVSNACAGMMTGVWLLDRMIRSGAVRSGMVVSGEQATRVARTAARELRDSYDPQFASLSVGDSAAAVVLDESTDPADRIHYIELMTCAAYSHLCLGMPSDRSQGIGLYTDNKKMHDRERLKLWPRFHEDFLAKNGRRFEDEEFDHIIQHQVGTRFIEYANRTAEAEFAAPMPPSLQVVEQYGNTATTSHFLTLRDHLRRTRGAGATGTGTGPGSGPGAGPAREAAGAKYLLVPAASGLVTGALSATVTHAGA	MKNSCASRELSVGELARRAGVAVSALHFYETKGLISSQRNAGNQRRFSRETLRRVVVIKVAQRVGIPLAEIARALQTLPAGRSPSAADWARLSAQWKEDLTERIDKLLLLRDQLDGCIGCGCLSLQACPLRNPGDQLSAEGPGAHWLDAEGREHDG	239.74	gnl|BL_ORD_ID|2395|hsp_num:0	2775			120	441	tigecycline; ciprofloxacin; acriflavine; tetracycline; rifampin; chloramphenicol; ampicillin; norfloxacin; cefalotin; triclosan
BGC0000382.1|Lipstatin_2 # 1587 # 2453 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.753	BGC0000382.1|Lipstatin_2 	1587	2453	+	Loose	575	27.7202	EAM-1	32.2	3006873	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	EAM beta-lactamase	ATGGGCATCGTCATCACCGCATCCGCGACCGCCACCCACACCGACCCCGGCACGCCCGCCTCCGCCGTCGACCTCGCCGGGCGCGCCGCACGCCGCTGCCTCGCCCACGCCCGCGTATCCCCGTCCGGCGTCGGCGTCCTCGTCAACGTCGGCGTCTACCGCGAGAACAACACCTTCGAACCGGCCCTCGCCGCCCTGGTCCAGAAGGAAACCGGCATCAACCCCGACTACCTCGCCGACCCGCAGCCCGCCGCCGGCTTCTCCTTCGACCTCATGGACGGCGCCTGCGGCGTCCTCAGCGCCGTCCAGGCCGGCCAGTCCCTCCTCTCCACCGGCACCACCGAGAGGCTCCTCATCACCGCCGCCGACGTCCACCCCGGCGGCGACGCCTCCCGCGACCCCGACTACCCCTACGCCGACCTCGCCGGAGCGTTCCTCCTCGAACGAGACGCCGACCCCGACACCGGCTTCGGCCCCGTACGCCACTACGGCGGCGGCGACCGGCCCACCGACGTCGCCGGCTACCTCGACCTCGACACCATGGGCAGCGGCGGACGCTCCCGCATCACCGTCCACCGCACCCCCGGCCACGAGCAGCGCACCGGCGAACTCGCCGCGGCCGCGGTCGCCGCGTACACCGGCGAGTTCGGCCTCGACGCCGGCCGCACCCTCGTCATCGGCCCGGACGCCCCCGCCGGCGTCGGCGACGGGCCGGGAGGAGGACGGCCGCACACCGCGGCCCCGGTCCTCGGCTACCTCCACGCCCTGGAAAGCGCCCGCCCCGAAGGCGTCGACACCCTCCTGTTCGTCACCGCCGGCGCCGGACCGCGAGCAGCCGTCGCCTCCTACCGCCCGCAGGGATGGTGA	MGIVITASATATHTDPGTPASAVDLAGRAARRCLAHARVSPSGVGVLVNVGVYRENNTFEPALAALVQKETGINPDYLADPQPAAGFSFDLMDGACGVLSAVQAGQSLLSTGTTERLLITAADVHPGGDASRDPDYPYADLAGAFLLERDADPDTGFGPVRHYGGGDRPTDVAGYLDLDTMGSGGRSRITVHRTPGHEQRTGELAAAAVAAYTGEFGLDAGRTLVIGPDAPAGVGDGPGGGRPHTAAPVLGYLHALESARPEGVDTLLFVTAGAGPRAAVASYRPQGW	MSVKALFAALPLLIAACAAIPAPQVEDADAPPSPAPTETVVNAHEMQMAFLDACEPWDEWDKPAPPFQLMGNSWYVGTCGISAVLITGEDGHILIDSGVPEAAPLVLANIASLGFDAKDVRYLLMSHEHFDHVGAHAAIKEATGAQVLASVRAKPVLETGKVAADDPQAASGHPDMTPVKVDRVIGDGEILDLGNLRVTAHETPGHSPGALSWTWWSCSLPGEPPVCNRFAYVDSLSAVSADDYRFTDHPEMVRAFRTSIDKARMLQCEFLVTPHPSAGSMLDLMSGEHGLYLHKGCGFYAKRLSKRLDERLAKEAAE	90.57	gnl|BL_ORD_ID|3516|hsp_num:0	4585			777	954	
BGC0000382.1|Lipstatin_4 # 5080 # 6771 # 1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.778	BGC0000382.1|Lipstatin_4 	5080	6771	+	Loose	1200	46.9802	arnA	25.0	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	GTGAAGATCCTGATCACCGGAGCCACCGGCTTCCTCGGCGGCCACCTCGCCGACGCCTGCCTGCGCTCCGGCCACGGCGTACGCGCCCTCGTCCGCCCCGGCAGCAACACCGACCGGCTGCGCGCCCTGCCCGGCGTCGAACTCGTCACCGGCGACCTCACCCGCCCCGACTCGCTCCGGCGCGCCGCCGACGGCTGCGAAGCCGTCCTGCACAGCGCCGCCCGCGTCGTCGACCACGGCACCCGCGCCCAGTTCACCGAAGCCAACGTCACCGGCACGCTCCGGCTGATGGACGCCGCCCGCGCCGCCGGCGTGCGCCGGTTCGTGTTCGTCTCCAGCCCGAGCGCGCTGATGCACCTGCGGGAGGGGGACCGGCTCGGCATCGACGAGACCACCCCCTACCCCACCCGCTGGTTCAACGACTACTGCGCGACCAAGGCCGTCGCCGAGCAGCACGTCCTCGCCGCCGACACCGCCGGCTTCACCACCTGCGCCCTGCGGCCCCGCGGCATCTGGGGGCCCCGCGACCACGCCGGGTTCCTGCCCCGCCTCATCGGCGCCCTGCACGCGGGACGCCTCCCGGACCTGTCGGGCGGCAAACACGTCCTGGTCTCCCTCTGCCACGTCGACAACGCGGTCGACGCCTGCCTGCGCGCCGCCGTGTCCGCACCGGCCGAACGCATCGGCGGCCGCGCCTACTTCGTCGCGGACGCCGAGACGACCGACCTGTGGCCGTTCCTCGCCGACGTCGCCGCCCGCCTCGGCTGCCCGCCGCCCGCACCCCGCATCCCGCTGCCCGCGGGCCGGGCGCTCGCCGCGGCGGTCGAGACGGCATGGCGCCTGCGCCCGGACGCCGCCGCCCGGGCCCGGTCGAGCCCGCCACTGAGCCGGTACATGATGGCCCTGCTGACCCGTTCGAGCACGTACGACACGACGGCGGCCCGCCGCGACCTCGGCTACACCCCCGTCCGCACGCAGGAGGACGGCCTGCGCGACCTGGTCCGCTGGGTCGCCTCGCAAGGCGGCGTCGCCTCCTGGACCGCCCCGCGCCCCCACCCCGCCCACACGCACACTCCGGACGCCACACCCCACGCCCCGGCCCGCGCCCCGCACCCGCCGATGCCCGAACCTCCGGCCGCGGCCACCCCCGCACCCCCGCCCAAGGCCGAACACCGCCCGGCCCTGCCCCGCCCGCGCTCCTCCCCCGAGGCGGACTCCACCGAACAGCCCTTCCCCCACCCCGCCGACGCCACGGACACCCCACCGGTGTCCGGCCCTGCACCGGGGCCGGTCTCCGTGCCGGCCCCCGACCGGACGCCTGCGCCGTCGGGCTCCTCGCGGACGGCCGGTGATGCGCCGGCGTGCCGTGCCGGACAGGCCTCCGGCCCGGCACCGGCGCCCGTACGCGGCCCTGCCGACGCCCGGTCCGCCGCCACGGGGCGCGGCCCCCGGCCGGTACGCGGTTCGGCAGAGCAGCGCGAACACCGCGACCCGTCCCTGCGCGCAAGCGGGAAACCGGGCAGCGACGGCTCCGGCGCCCCTGCCGACACCCGCCCGAACCACGACCCGACTCGCGCCGAAGCAGCACGGCCGGGAGACGCGGGGAGGGGCATGGCGCCCGAAGGGGACACCGCGCGCCGCGGATCCACCGATCCGGCCGGACCTGCCGGCCGAGAGGACACCTCACGATGA	MKILITGATGFLGGHLADACLRSGHGVRALVRPGSNTDRLRALPGVELVTGDLTRPDSLRRAADGCEAVLHSAARVVDHGTRAQFTEANVTGTLRLMDAARAAGVRRFVFVSSPSALMHLREGDRLGIDETTPYPTRWFNDYCATKAVAEQHVLAADTAGFTTCALRPRGIWGPRDHAGFLPRLIGALHAGRLPDLSGGKHVLVSLCHVDNAVDACLRAAVSAPAERIGGRAYFVADAETTDLWPFLADVAARLGCPPPAPRIPLPAGRALAAAVETAWRLRPDAAARARSSPPLSRYMMALLTRSSTYDTTAARRDLGYTPVRTQEDGLRDLVRWVASQGGVASWTAPRPHPAHTHTPDATPHAPARAPHPPMPEPPAAATPAPPPKAEHRPALPRPRSSPEADSTEQPFPHPADATDTPPVSGPAPGPVSVPAPDRTPAPSGSSRTAGDAPACRAGQASGPAPAPVRGPADARSAATGRGPRPVRGSAEQREHRDPSLRASGKPGSDGSGAPADTRPNHDPTRAEAARPGDAGRGMAPEGDTARRGSTDPAGPAGREDTSR	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	85.05	gnl|BL_ORD_ID|1513|hsp_num:0	1643			954	1494	polymyxin B
BGC0000382.1|Lipstatin_5 # 6768 # 11513 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.782	BGC0000382.1|Lipstatin_5 	6768	11513	+	Loose	1000	90.5077	almE	27.59	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGAGCACCAGCACACCGAACCCGCCCGGCACCTCGGAACCACAGCGGGTGTCCCGCTCGGCGGCCGCGTCCGACCTGCCGAGCCCGACCGGCACTCCGGGCTCGCCCGGGGCACCCGGCGCCTCCGTTCCCCGGGCCTCGTCGGAGGCGTCCGGCCCGGCTGCCGCCGCAGGCCGCCCTTCCGGCGCGCTCCCGGCGCCCGAGCCGTCCGCCGCCGTGCCCGGCGCTTCGACCTCACCGCAGGTGCCCCGGTCACCCGCACCCGCGGCGCCCGGCACGGCGAGCCAGGCCGGCACCCCGGGCCCGGCGGAGGATGCGGGCTCTCCCGCGGCCTCCAGCGCTTGCACCGCGCCGGTGTCGCCGGGTTCGTACCTCGCGTCAGGCAACACGGTGTCGCCGTCGCCCAGCCCTTCAGCCCTGCCGGCGACACCCGGCACAACCGTCGCACCCGGTGCGGCGGGAGGGCCGGAGCTGCCGGAGGCGGTCGGCTCGGCCACCCTGCCCGGCGCTTCCGGCACGCCGGAGGCACGCCGGTCATCCACCGCCGGCGGTGGATCCGGACCGCACAGTTCGGACGCCACGGCCGCGGCCGCGTACCGGCGGCCCGTGTCGCCCACCGAGAGGCTCTACCTCGCCGCGGGGGAGCCGCGCGGCGCCATGGCCCTGCGGATCGTCGTCGAAGGCGACGGCCTGCCCGACGCCGGGCAGCTCCACGCCGCCGTCGCACGGGCCGCGGAGACGTGCCCCGGATCCCGGCTTGTCCGTCGCGGCCCCCTGTGGGCGGCGGACGGTCCGCCGCCGCACATCGTCCACGCGGCGGCCGCCGAGGGCCCGTTCGACGTGTCGGACCCGCGCACCGCTCGCCTCCTCACCGGCCGATCCGGCCCGGGGGACCAGCCCGGGTGCGAGCTGCTCGTCGTGCCCGGTGCGGGCGGGGCCCGTAGCACGCTCGTGTTCAGCGCCTCGCACGCCCTGATGGACGGGCACGGCGCCCTCACCTGGGTGCGGGAGGTATTCCGCGCCCTCCGAGGCGAAGCCGCCAGGCCCGCCGCCGACCCGTCCACCGACCTCGGCGTGCTGCGCCGACTCGCCGCGGACCGGGGCGGCCGCCCCCGCCGACGGCCCGCGCCGCTCCCCGGACGGCGCTCCCCGCTCGGCCCCGCCTCGGCCACCGGCTCTGCGTCGCAGACGCTGTGGCTGCGCCGCACCCTGCCCGGCCGGCACCCCGCGCTCACCGCCCGGCTCGCCCAGGCCGTCGCCGACACGGCACGGCTCGACACGCGCGCCATGGTTCCCGTGGACCTGCGCCGCCACCTCCCGCACCTCGCCGCCGCCACCGGCAACCTGACCCTGCCCCTCTTCCTCGACCTGCGCCCCGGCCAGGACTGGGCCGCCGCCCACACCCGCCTGCTGACCGCACTCGCCGCGGGCGGCGAACTCGCCGCCGGGTTCGAATCCGGGCCCGTCAGCCGCCTGCCCCAGCCGGCCGTCGCCGCTCTGCTGCGCGCCGCGCAGGCCGCCGCCGTACGCGCCGACCGGCACCTGGCCTCCGCCGTCGTCTCCCACCTCGGACGGCTCGACACCGGCGAACTCTCCGGCGGCGGGTTCACCGCCGCCACGGCCTATGCCCTGCCCGTGCACGCCCCGCTGGTGCCGCTGTCGTTCGCCGTCGCGGAGACGCCCTACGCGATCGAGATCACCCTCGGCGTCCGCGCCACCGACCCGTCCCTCCCCCACCGCGCCTCCGCCTTCCTGGACTCCGTACTCGCCGTACTCGCCGCGGACGGCGCCGGCCCGCGTACGAACACCACACCCGCCCGAACCGCCGCATCCGACCCGTCTGCCACGACTGCCGAATCCGGCCCGGCCGATGCGTCCGCGCCGGCGTCCACCCGGACTGCCCCGGCTGACGTGTTGACCCCGTCCGCCTCGGCCGGCGCATCCGGCGTGTGCGCCCCGCCCGGCTCGGCCGGCGAAGCCGCCCCGGATGCGTCGTCCGCCCCGGCCGCCTCGGTTGGCGCGTACCCCCCGGTCGGTGCGTCCGCCGCGTCCGACGCGTCGACCCAGATTGCCCCGGCCGACGCATTGACCCCGGCCGCCTCGGCCGGCGGGTTCCCCCCGGATGCCCGGTCCGTCCCGGCCGCCTCGGTTGGCGCATATGTACCGGTCGATGCGTCCGACGCGTCCACCTGCTCCGCCCCGGCCGGCGCGTCCGCCCCCACCACCTCCGCTGACGCATCCGGCGCGTGCGTTGCGTCCGCCTCGGCTGACCTGCCCGCCCCGGTTGTCCTGGGTGACACGTCCGACTTGGCCGAGGTGTCCGGCGCATCCGGCCGGACCGCCCAGGCTGACGCGTGCACCCCGTCCGTCCCGGCTGACGGGTCCGCCCCGGTCACCCCGGCCGACGCGTCCGACGCGTCCGCCCGGACCGTCCCGGCCGACGCGACCGCCGCGGGCACCGTCGTCGACCTCTTCCGCGCACAGGCCGCCCGTACGCCCGCGGCCGTCGCCCTCGACGGGCCCGCCGGGCCGGTAACCTACGCGGAGCTGGACCGGCGTTCCGACGCGGTCGCCGCCGAGCTGGTGCGGCGCGGGACCGCCCGCCGCGACCTCGTCGGCCTGGTGGTGGACCGCACCCCGGAGGGCGTGGCCGGGCTGTGGGGCATCCTCAAGGCCGGCGCCGCCTACGTCCCCCTCGACCCGGCCCACCCCGGCCCGCGCATCCGCGGTGTCCTCGCATCCTGCGGCGTCCGGCTGACGCTGACCCGGCGCCACCTGGCGGCCCACCTCGCCGAGTTCGTCCCGGGCGCGCTCCTGGCCGTCGACGACGTACCGACGCCCGCGCAGCCCCCGTTCGCCCCTGTGGCCACCGGACCCGCCCCCGGCGACCTGGCGTACGTCATGCACACCTCCGGCTCGACCGGCCACCCCAAGGGCGTGCTGATCGAGCACCGCGGGCTGGTCGCCTTCGCCCGCTGGATGACGGACCTGTGCCGCGTCGGCGAAGGCACCCGCTTCGGATTCGCCTCCTCCTACGCCTTCGACATCTCCTGCTTCCCGCTGTTCCTGCCCCTGCTGGCCGGCGGAACGGCCGTCCTCGCCCCCGGCGCGCCGTCCCCCGCGACCCTCCGCGCGCTCGTCGGTGAACACCGCGCCGACACGCTCGCCCTGACGCCGTCCCACCTGGCACTCCTCGACGGCGACGGCGGCGGCCCCCTCAGCACCCTCCTGCTCGGCGGCGAGGAGCTGACCCCGGCGGCCGTCCGCTCCGCGTACGCCGCCTTCGGCACCGGCTGCCGGCTGATCAACGGCTACGGGCCCACCGAAGCCACCGTCGCCTGCCTCGCGCACGTCGTCGACGACACGGAGACGGGCCCCTCGCTGCCGCTCGGCACACCCGGCCCGGACCTCCGCGTCGACCTGGTCGCGGAAGACGGCGCGTCCGTCGGAACCGGCCCGGACGACGTCGGCCGCGTCGGCGAGATCGTCGTCCACGGCATCCAGGTGGCCCGCGGCTACCACGGTTCGGTGTCCGCCGAACCGGACGGCACGGTCGGGCCGTTCTCAACGGGGCCCGACGGGCTGCGCTCGTACCGCACCGGCGACCTCGGACGCCGCCTCCCCGGCGGCGGCATCGCCTTCGCCGGGCGGGCAGACGGCCAGGTGAAGGTGGCCGGCCACCGCATCGAGCCCGCCGAGATAACCGCCGCCCTGGAGGCCCACCCCGGCGTCGCCCGGGCCGCGGTCACGACCCGCCGCCGCCCCGGCGGACGGGGGCTGGTCCTGTGCGCATACGCGGTCCCGTCCACCGGCACGGCAACCACGGGCCCGACGGCCGCCCCCGCCGCCGGCGCCGGCGGCCCTGCGGACCCCGGCACCGCGGAATCCGGTCCTGCCTACAGCGGCCCTGCAGCCGCGGGCCCGGCGGACTCCGGCTCTGCTGCCACCGGCACTGCAACCACGGGCCTGGCGATCACCGGCACCGTGGCCGCCGGCGGCCCTGCGGACCCCGGCACCGCGGACGCCGGCTCTGCCCGCACCGGCCGTGCGGGCACAGGCCGGTTTGACTCCGGCCCGGCGGGTTCCGGCTCGGCGGTCACCGGCCGGTCGGGTTCCGGCTCGGCGGTCACCGGTGCGGTGGGCTCCGGCCCTGCGGCCACGGGTTCGGCGGACTTCGGCCGTGCGGCCACCGATCCGGCGGGCTCCGGCCCGTCGGACCCCCGCTCCGGCCCCCCGGTGCCCCCCGCCGGCGCGCCTTCGGCGGCGGAGCTCCGCGCCCACCTGGCCGGGATCCTGCCCCGGCACCTGGTCCCGGCCCACATCCTCACCGTGCCGGGCCTCCCGACCACCGTGAGCGGCAAGACGGACTTCGACGCGCTCCCGGACCCGTTCGCCGGAACCGCCCCGCTCCCGGCCGAGCCGGACGGGCCCGCCGCGCCGCACGACACGTACGACGCGGCCCCCGATCCCCGCAGCAGCCGCAAGGCGCTGCGCTCCCGCGTGGCCCGCCACTGGGCGACCGTCCTCGGCATCGACGCCGCAGCCCTGACCGCCGACTCGGACTTCCAGGCGCTCGGCGGCGATTCGCTCGCCCTCGTCGAGATGCTGAGCGCCGTCAGCGCCGACCTGCTCACCCCGGACGAAACCCGCCGCTTCACCGGGGACCTCACCGTCCTGGTCCGCGACCTGACCCTCGACCGGGTCTGCGACCGCCTCGCCGCCGTACGCGAAGGAACCACCGCATGA	MSTSTPNPPGTSEPQRVSRSAAASDLPSPTGTPGSPGAPGASVPRASSEASGPAAAAGRPSGALPAPEPSAAVPGASTSPQVPRSPAPAAPGTASQAGTPGPAEDAGSPAASSACTAPVSPGSYLASGNTVSPSPSPSALPATPGTTVAPGAAGGPELPEAVGSATLPGASGTPEARRSSTAGGGSGPHSSDATAAAAYRRPVSPTERLYLAAGEPRGAMALRIVVEGDGLPDAGQLHAAVARAAETCPGSRLVRRGPLWAADGPPPHIVHAAAAEGPFDVSDPRTARLLTGRSGPGDQPGCELLVVPGAGGARSTLVFSASHALMDGHGALTWVREVFRALRGEAARPAADPSTDLGVLRRLAADRGGRPRRRPAPLPGRRSPLGPASATGSASQTLWLRRTLPGRHPALTARLAQAVADTARLDTRAMVPVDLRRHLPHLAAATGNLTLPLFLDLRPGQDWAAAHTRLLTALAAGGELAAGFESGPVSRLPQPAVAALLRAAQAAAVRADRHLASAVVSHLGRLDTGELSGGGFTAATAYALPVHAPLVPLSFAVAETPYAIEITLGVRATDPSLPHRASAFLDSVLAVLAADGAGPRTNTTPARTAASDPSATTAESGPADASAPASTRTAPADVLTPSASAGASGVCAPPGSAGEAAPDASSAPAASVGAYPPVGASAASDASTQIAPADALTPAASAGGFPPDARSVPAASVGAYVPVDASDASTCSAPAGASAPTTSADASGACVASASADLPAPVVLGDTSDLAEVSGASGRTAQADACTPSVPADGSAPVTPADASDASARTVPADATAAGTVVDLFRAQAARTPAAVALDGPAGPVTYAELDRRSDAVAAELVRRGTARRDLVGLVVDRTPEGVAGLWGILKAGAAYVPLDPAHPGPRIRGVLASCGVRLTLTRRHLAAHLAEFVPGALLAVDDVPTPAQPPFAPVATGPAPGDLAYVMHTSGSTGHPKGVLIEHRGLVAFARWMTDLCRVGEGTRFGFASSYAFDISCFPLFLPLLAGGTAVLAPGAPSPATLRALVGEHRADTLALTPSHLALLDGDGGGPLSTLLLGGEELTPAAVRSAYAAFGTGCRLINGYGPTEATVACLAHVVDDTETGPSLPLGTPGPDLRVDLVAEDGASVGTGPDDVGRVGEIVVHGIQVARGYHGSVSAEPDGTVGPFSTGPDGLRSYRTGDLGRRLPGGGIAFAGRADGQVKVAGHRIEPAEITAALEAHPGVARAAVTTRRRPGGRGLVLCAYAVPSTGTATTGPTAAPAAGAGGPADPGTAESGPAYSGPAAAGPADSGSAATGTATTGLAITGTVAAGGPADPGTADAGSARTGRAGTGRFDSGPAGSGSAVTGRSGSGSAVTGAVGSGPAATGSADFGRAATDPAGSGPSDPRSGPPVPPAGAPSAAELRAHLAGILPRHLVPAHILTVPGLPTTVSGKTDFDALPDPFAGTAPLPAEPDGPAAPHDTYDAAPDPRSSRKALRSRVARHWATVLGIDAAALTADSDFQALGGDSLALVEMLSAVSADLLTPDETRRFTGDLTVLVRDLTLDRVCDRLAAVREGTTA	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	284.35	gnl|BL_ORD_ID|4935|hsp_num:0	5928			582	1389	colistin A; colistin B
BGC0000382.1|Lipstatin_6 # 11510 # 12202 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.763	BGC0000382.1|Lipstatin_6 	11510	12202	+	Loose	1200	53.1434	arnA	29.46	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGATCTTCGTCGGAGAGGGCGCCCTGCTGCGCCGGGCCGTCTCCCACGCCGCCGCCCGAGGCCACCGCGTCGACCTGGTCTGCTCGCCCGACCCGCTCGACGCAGCGGCCGCCGCCCCCGGCACGCCGCACCTTGCCGCGCCCGACGTCAACGCCGCGGCCGCCGACCTGGCGGCGGCCTGCACCGACGGGATCGTCTGGTCGGTCAACAACCGGCAGCTTTTCCGTGCCCCGGTGCTGTCGCTGGGGCTCCGCATCGTCAACGTCCACAACGGGCTGCTGCCGCAGCACCGCGGACTGCCGTCCGCCGCCGTCGTGTTCGCGCTGCTCCACGGGGACACCGAGTACGGGGCCACCGTGCACGAGGTCGACGCCGGCATCGACACCGGCCCCGTCCTCGCCGAGCACCGCTTCCCGATCGGGCCCGCCGACCGCTTCCACGAGGTGATGCTGCGCGGCGTCCGCGCCTGCCAGACCCTCTTCGAGCGGACGCTGCCCGCCGTGGCCGCCGGCGAACGCCCCCGAGCCGCCCCGCCGGACGCCGCCCGGCCTTCCGGGTACTACGGGCGTCGGGCCCTCGCCCGCCTCGGGGAGCACCGCGACGCCCCCTCCTTCGTACGCGCCACCGACCTCGGCCCCTTCGCGGCGCACGCACCCGAAGTCGCCGAGGCCCTGCACCGCGTACGCCCCTGA	MIFVGEGALLRRAVSHAAARGHRVDLVCSPDPLDAAAAAPGTPHLAAPDVNAAAADLAAACTDGIVWSVNNRQLFRAPVLSLGLRIVNVHNGLLPQHRGLPSAAVVFALLHGDTEYGATVHEVDAGIDTGPVLAEHRFPIGPADRFHEVMLRGVRACQTLFERTLPAVAAGERPRAAPPDAARPSGYYGRRALARLGEHRDAPSFVRATDLGPFAAHAPEVAEALHRVRP	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	34.74	gnl|BL_ORD_ID|1513|hsp_num:0	1643			237	612	polymyxin B
BGC0000382.1|Lipstatin_7 # 12344 # 12547 # -1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.828	BGC0000382.1|Lipstatin_7 	12344	12547	-	Loose	1900	22.3274	acrD	26.42	3000491	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCCCGGCGTGCCGGACGGGGTGGCGTTCCGCCGCATCGGGGCGGCAGCGGGACCGGCTTCCGACGTGGCCGCCGCCGTCGACGACGACGACGTGACGGGCCTGCGCGGCCGGGCGGGGGGCCGGGCAGGAGGGGCGGGATCCGCCCAGGCCGCGGCCGGGGCGGAGCTGCCGCGGGCCGGCGGATCGGACGCGGACGCGTAG	MPGVPDGVAFRRIGAAAGPASDVAAAVDDDDVTGLRGRAGGRAGGAGSAQAAAGAELPRAGGSDADA	MANFFIDRPIFAWVLAILLCLTGTLAIFSLPVEQYPDLAPPNVRVTANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSGTGQASVTLSFKAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSFQMTAKDVTDAIESQNAQIAVGQLGGTPSVDKQALNATINAQSLLQTPEQFRDITLRVNQDGSEVRLGDVATVEMGAEKYDYLSRFNGKPASGLGVKLASGANEMATAELVLNRLDELAQYFPHGLEYKVAYETTSFVKASIEDVVKTLLEAIALVFLVMYLFLQNFRATLIPTIAVPVVLMGTFSVLYAFGYSVNTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLTPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPLKKGEHHGQKGFFAWFNQMFNRNAERYEKGVAKILHRSLRWIVIYVLLLGGMVFLFLRLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVEQIEKYYFTHEKDNIMSVFATVGSGPGGNGQNVARMFIRLKDWSERDSKTGTSFAIIERATKAFNQIKEARVIASSPPAISGLGSSAGFDMELQDHAGAGHDALMAARNQLLALAAENPELTRVRHNGLDDSPQLQIDIDQRKAQALGVAIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAPYRMLPDDINLWYVRNKDGGMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGVSTGTAMDIMESLVKQLPNGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNQKGHDLFEATLHACRQRLRPILMTSLAFIFGVLPMATSTGAGSGGQHAVGTGVMGGMISATILAIYFVPLFFVLVRRRFPLKPRPE	6.46	gnl|BL_ORD_ID|1309|hsp_num:0	1427			150	303	
BGC0000382.1|Lipstatin_8 # 12714 # 13334 # 1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.717	BGC0000382.1|Lipstatin_8 	12714	13334	+	Loose	300	28.8758	dfrA21	28.0	3003017	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	GTGCGCCGACTCGTCTACTACATCGCCACCACGCTCGACGGCTTCATCGCCGGCCCGGACGGCGCCGACCCGACCGGCCCGAACGGCTTCTGGCCGATCGCGGAGGACTACCTCCAGCACCTCGTGGCCGAGTACCCGGAGACCCTGCCGGTCCAGGCCCGGCAGGCGCTGTCCGTCACCGCCGAGGGCACCCGGTTCGACACCGTCCTCGAAGGGCGTCGCACGTACGAGATCGGCCTCGCGGCCGGCATCCCCGACGCCTACCCCCACCTGCGGCACATCGTGTTCTCCCGCACCCTCACCGAGCTCCCGGCCCCGGCGGTCGAGCTGGTCTCCGGCGACCCGGTGGCGACCGTGCGCGAGCTGAAGCAGCAGGACGGCAAGGACATCTGGCTGATCGGCGGCGCCGAGCTGGCCGGCTCCCTCTACGCCGAGATCGACATGCTCGTCCTCAAGGTCGCGCCGCTCACCCTGGGCGACGGCATCCCGCTCTTCTCCCGCAAGGCCGCCTTCGACCCGCGCACGTGGACGCTCACCGACCACACGGTCCTGAAGAGCGGGGCGGCGTTCCTCACCTACACCCGCCCCACCGACACCGACACCGACACCGACACCGCCTGA	MRRLVYYIATTLDGFIAGPDGADPTGPNGFWPIAEDYLQHLVAEYPETLPVQARQALSVTAEGTRFDTVLEGRRTYEIGLAAGIPDAYPHLRHIVFSRTLTELPAPAVELVSGDPVATVRELKQQDGKDIWLIGGAELAGSLYAEIDMLVLKVAPLTLGDGIPLFSRKAAFDPRTWTLTDHTVLKSGAAFLTYTRPTDTDTDTDTA	MNPESVRIYLVAAMGANRVIGNGPDIPWKIPGEQKIFRRLTESKVVVMGRKTFESIGKPLPNRHTVVLSRQARYSAPGCAVVSTLSQAIAIAAEHGKELYVAGGAEVYALALPHANGVFLSEVHQTFEGDAFFPVLNAAEFEVVSSETIQGTITYTHSVYARRNG	124.85	gnl|BL_ORD_ID|136|hsp_num:0	157			120	321	trimethoprim
BGC0000382.1|Lipstatin_9 # 13464 # 14072 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.764	BGC0000382.1|Lipstatin_9 	13464	14072	+	Loose	400	31.187	tetR	30.19	3003479	protein overexpression model	n/a	n/a	tetracycline antibiotic	antibiotic target alteration; antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGCACGACCCCGCGGCGTCGAGGACGCGGTGATCCTGCGGGCCGCCGTCGACGTGATCGGCCGGTCCGGGCCCGGCGGCCTCACCCTGGCCGCCGTCGCCCGCGAAGTCGGGCTCGTCCCCGGCACGCTCGTGCAGCGGTTCGGCTCCAAGCGCGGCCTGCTCCTCGCGCTCGCCGAGCAGGCCGCGCGCGAAGCGGAGGACCTGCCCGTCCGCGCCCGCCAAGGCCACGACAGCCCCCTCGCCGCCCTGGAGGCGCTGCTCGTCTCCTCCACGGAGCACATGGCGACACCCGAGGCGTTCGCGCACCATCTGGGATTCCTGTGCATCGACCTGACGGACCCGGAATTCCACCGCCACGCCCTCGCCGTGCACCGCGCCCAGCAGCGCGCCGTCGAAGCCCTCCTCGGCGAGGCGGCCGGGGCCGGGGAGCTCCGCCCCCGTACGGACACCGCCGCGCTCGCGGCGACCGTACAGGCCGCCGCAGCAGGCGCCGGCCTCGTCTGGGCCCTCGACCGCAGCGGCAGCCTCGCCGACCGTGTGCGCCGCGAACTCGCCGCCGTACTCCGCGCCCACCAACCCCACCACCCACGCCCGGAGGAACGATGA	MARPRGVEDAVILRAAVDVIGRSGPGGLTLAAVAREVGLVPGTLVQRFGSKRGLLLALAEQAAREAEDLPVRARQGHDSPLAALEALLVSSTEHMATPEAFAHHLGFLCIDLTDPEFHRHALAVHRAQQRAVEALLGEAAGAGELRPRTDTAALAATVQAAAAGAGLVWALDRSGSLADRVRRELAAVLRAHQPHHPRPEER	MMSRLDKSKVINSALELLNEVGIEGLTTRKLAQKLGVEQPTLYWHVKNKRALLDALAIEMLDRHHTHFCPLEGESWQDFLRNNAKSFRCALLSHRDGAKVHLGTRPTEKQYETLENQLAFLCQQGFSLENALYALSAVGHFTLGCVLEDQEHQVAKEERETPTTDSMPPLLRQAIELFDHQGAEPAFLFGLELIICGLEKQLKCESGS	97.12	gnl|BL_ORD_ID|442|hsp_num:0	276			12	171	tetracycline
BGC0000382.1|Lipstatin_10 # 14069 # 14989 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=3-4bp;gc_cont=0.751	BGC0000382.1|Lipstatin_10 	14069	14989	+	Loose	2200	26.9498	Bifidobacterium bifidum ileS conferring resistance to mupirocin	31.71	3003730	protein homolog model	n/a	n/a	mupirocin-like antibiotic	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	ATGACGTACGCCACCCCCGCCCGGCCCCTCGCCGGCAAGGTCGCCCTCGTCGCCGGCGGCACCCGCGGCGGAGGCCGCGGCACGGCCGTCGCCCTCGGCGCGGCCGGCGCGACGGTGTACGTCACCGGCCGCAGCAGCCGCACCGCCGGCCGCTCCCCCCTCGACCGCCCCGAGACCGTCGAGGAGACCGCCGCCCGGGTCACCGCTGCCGGCGGCCTCGGCATCCCCGTACGCGTCGACCACAGCGACCCCGACGAAGTCCGCGCCCTCACCGCCCGCATCGGCGCCGAGCAGTCGGGCCGGCTCGACATCCTCGTCAACTCGGTCTGGGGCGGCGACCCGCTCACCGACTGGGAGCACCCGCTGTGGGAGCAGGACCTCGACACCGGCCTGCGGCTGCTCCGCCAGGCCGTCGAGACGCACATCATCACCAGCCGCCACGCCCTCCCCCTGATGGTCGCGCAGGGCAGTGGGCTCGTCGTCGAGGTCACCGACGGCAACACCGCCCGCTACCGCGGCTCGTTCTTCTACGACCTCGCCAAGTCGGCCGTCATCCGCCTCGCCTTCGCCCAGGCCGCCGAACTGAGGGAGCACGGCGTCGCCGCCGTCGCCGTCACCCCCGGCTTCCTGCGTTCCGAGGCGGTGCTCGACCACTTCGGCGTCACCGAGGACACCTGGCGCGACGCCGTCGCCCGGGATCCCGACTTCGCGCACTCCGAAAGCCCCGCCTACCTGGGCCGCGCGATCGCCGCCCTGGCCGCCGACCCGGACGTCCTGCGGTGGACGGGCCGCGCCCTCGCAACCTGGTCCCTGTACAAGGAGTACGGCTTCACCGACACCGACGGCACCCAGCCCGACTTCGCCGCCCACTGGGCCGATGCCCTCGAACCGGTCCACGGCCCCCTCGGCGAGCCGCTGTAG	MTYATPARPLAGKVALVAGGTRGGGRGTAVALGAAGATVYVTGRSSRTAGRSPLDRPETVEETAARVTAAGGLGIPVRVDHSDPDEVRALTARIGAEQSGRLDILVNSVWGGDPLTDWEHPLWEQDLDTGLRLLRQAVETHIITSRHALPLMVAQGSGLVVEVTDGNTARYRGSFFYDLAKSAVIRLAFAQAAELREHGVAAVAVTPGFLRSEAVLDHFGVTEDTWRDAVARDPDFAHSESPAYLGRAIAALAADPDVLRWTGRALATWSLYKEYGFTDTDGTQPDFAAHWADALEPVHGPLGEPL	MSETTNSHVYPKANEGGETASVAPNPSFPNMEETVLKYWDKDDTFNKSVERNPSGDHSQNEFVFFDGPPFANGLPHYGHLLTGYAKDVIPRYQTMKGRKVNRVFGWDTHGLPAELEAQKELGIDSVDQIEKMGIDKFNDACRASVLKYTHEWQDYVHRQARWVDFEHGYKTLNIPYMESVMWAFKQLYEKGLAYQGYRVLPYCPKDQTPLSAHELRMDADVYQDRQDTTVSVAVKLRDEEDAYAVFWTTTPWTVPTNFAIVVGADIDYVEVRPTQGKYAGKKFYFGKPLLSKYEKELGEDYEVVRELKGSEMAGWRYWPVFPYFAGDKAESEGNVPGPEGYQIFTADYVDTVEGTGLVHQAPYGEDDMNTLNAHGIKSTDVLDAGCRFTAQCPDYEGMYVFDANKPILRNLRNGDGPLAEIPAEHRAILFQEKSYVHSYPHCWRCATPLIYKPVSSWFVSVTKIKPRLLELNQQINWIPENVKDGQFGKWLANARDWSISRNRFWGSPIPVWVSDDPKYPRVDVYGSLEELKADFGDYPRDKDGNVNMHRPWIDNLTRVNPDDPTGKSHMHRISDVLDCWFESGSMSFAQFHYPFENKEKFEQHFPADYIVEYIGQTRGWFYLLHVMATALFDRPAFKNVICHGIVLGSDGQKMSKHLRNYPDVNGVFDKYGSDAMRWFLMSSPILRGGNLIVTAEGIRDTVRQVMLPVWSSYYFFTLYANAANGGAGFDARQLRADEVAGLPEMDRYLLARTRRLVERVEKSLDEFAISDACDAASDFIDVLTNWYIRNTRDRFWKEDVNAFNTLYTVLEVFMRVLAPLAPMESESVWRGLTGGESVHLADWPYVADEKTGEATELGRVLVDDPALVDAMEKVREIVSGALSLRKAAQIRVRQPLAKLTVVVEDVDAVKAYDEILKSELNIKDIEFCTMEDAGSQGLKIVHELKVNARAAGPRLGKQVQFAIKASKTGAWHVDAATGAPVVETPNGEVALEAGEYELINRVEEENAAEADASVSAALPTGGFVILDTVLTADLEAEGYARDVIRAVQDARKAADLDIADRIALVLTVPSANVADVERFRDLIAHETLATSFAVKEGAELGVEVAKA	27.64	gnl|BL_ORD_ID|4694|hsp_num:0	2278			57	180	mupirocin
BGC0000382.1|Lipstatin_12 # 15965 # 16867 # -1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.785	BGC0000382.1|Lipstatin_12 	15965	16867	-	Loose	550	43.1282	NmcR	27.56	3003665	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	NmcA beta-lactamase	ATGGATGGCGTGGAGCTGCGGCACCTGAGGGCCCTGGACGCGGTCGCCGCGGCTGGCACGGTCACCGCGGCCGCGGCGCGGCTGCACATCACCCAGCCGGCGCTGTCGCGGACGCTGGCGCAGCTGGAGGCGCGGGTCGGGGTGCGGCTCGTCGACCGGTCCTCGCGGCGGCCGGCCCTGACCGCCGCGGGCACGACGCTGCTCGGGCACGCCCGGGCCATCCTGGCGCATCTGGACGCGGCCCTCGCCGACACGCGGGAGGTGTCGCGGCCGCTGCGCCTGGGCTACACGTGCGCGGTGCTCGGGCAGCAGACGGTGCCGCTGCTGCGCTCGTGGCGGCGTACGCACCCGCACGTCCCGCTGGAGGTGGTGCGGCATGACAGCAGTACCGCGGGCCTGGCCACGGGGGACGCGGACCTGGCGGTGCTGCGCACGGTGCCGGCGGACCGGCGGATCCGCACGGAGGCGCTGTACACGGAGGGCCGGGTCGCCGCGCTGCCGGACGACGATCCGCTGGCGGGCAGGGATCAGGTGCTGCTGGCGGAGCTGACGGCGGGCCGGGATCTGCCGCTGGCCCTGTGGCCGGAGACGGGCACGGCGTCGCCGGAGCTGTGGCCGGCGGGGCGGCGGCCGGCCCGGACGGTGGAGGTCCGCAACGTGGACGAGTGGCTGAACCTGATCGCGATCGGCGGGGCGTTCGGCGTCGGCGCGGCGGGCACGGCGGAGAGCCACGGCCACCCGGGCGTCCGCTTCGTGCCGGTGGCGGACGCTCCGGCGGCCACCGTGTACCTGGCGCGGCCCGCGCACCCCACGCACCCGCGGACGGACGACTTCCGGGCGGCGGTCCGCGACGTGGTGAGCGGCGGCGGGGACGGCGGCGACGGCCGCGCGTCCGGCGCCTGA	MDGVELRHLRALDAVAAAGTVTAAAARLHITQPALSRTLAQLEARVGVRLVDRSSRRPALTAAGTTLLGHARAILAHLDAALADTREVSRPLRLGYTCAVLGQQTVPLLRSWRRTHPHVPLEVVRHDSSTAGLATGDADLAVLRTVPADRRIRTEALYTEGRVAALPDDDPLAGRDQVLLAELTAGRDLPLALWPETGTASPELWPAGRRPARTVEVRNVDEWLNLIAIGGAFGVGAAGTAESHGHPGVRFVPVADAPAATVYLARPAHPTHPRTDDFRAAVRDVVSGGGDGGDGRASGA	MRARLPLNALRAFEASARYLNFTKAGLELHVSQAAVSQQVRTLEQMLGVALFTRVPRGLQLTDEGMHLLPSITEALQMMSSAMDKFHEGKIKEVLTIAVVGTFAIGWLLPRITAFLNENPWIDIRILTHNNVVNLAAEGIDASIRFGTGGWINTENILLFQAPHTVLCSPETSKKLYIPSDLKKVCLLRSYRKEEWNNWFKAAGIDPWTITGPIFDSTRLMIDAVKLGDYAALVPYHMFQKELNERSVAKPFEIYATLGGYWLTLQKSRVNHNSEALNVFKEWIIEHSREFVLKS	101.69	gnl|BL_ORD_ID|1905|hsp_num:0	2072			18	393	cefoxitin; cefazolin; ampicillin
BGC0000382.1|Lipstatin_13 # 16985 # 17587 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.755	BGC0000382.1|Lipstatin_13 	16985	17587	+	Loose	400	24.6386	ErmU	37.14	3001305	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGGTGAGGATCCTCCTGGTCGGAGCGGGCGGCACGCTCGGCGGCGCGGTACGCGCGGCGCTGTCGGAACGCGGACACGAGGTGGTCGGCGTCGGCCGCACCGGCGGCGACCTGGTCGCCGACGTCACCGACCCGGAGGCCGTCGCCCGCCTGTACGCGCAGGCCGGCCCGCTGGACGCGGTCGCGGTCGCCGCGGGCGACGCCGTCTTCCGCCCGCTCGCCGAACTGACCGCCGACGACATCGCGGCGACCCTGCGCGGCAAGGCGCTCGGCCAGCTGGAACTCGTCCGCCAAGGCGCCCGGCACGTGGCGCCGACCGGCTCGTTCACGCTGATCAGCGGCATCCTCACCGAGGAGCCGATCCCCGCCGGAGCGGCCGCCTCCGCGGCGAACGGCGCCGTCGAGGCCTTCGTCCGCGCCGCCGCGATCGAACTCCCGCCCCAGCGCATCAACGCGATCAGCCCCACCGTCGCCGAGGAGTCCCTCCCCGCGTACGCCCCGTTCTTCCCCGGAATGGAACCGGTCCCCGCCTCCCGCGTGGCCACGGCATACGTCCGCTCGATCGAGGGCGCCCAGACGGGCCGGATCTACCGCGTCCACTGA	MVRILLVGAGGTLGGAVRAALSERGHEVVGVGRTGGDLVADVTDPEAVARLYAQAGPLDAVAVAAGDAVFRPLAELTADDIAATLRGKALGQLELVRQGARHVAPTGSFTLISGILTEEPIPAGAAASAANGAVEAFVRAAAIELPPQRINAISPTVAEESLPAYAPFFPGMEPVPASRVATAYVRSIEGAQTGRIYRVH	MPSRYGSRQDLGQNFLVDPDIIKLIRRAPNERKVPSLIWRRRGHVTLPLSRLGRPVTAVELDPRRVKRLSARAPENVKVVGEDILRFRLPTVPHTVVGNIPFHVTTATMRRILVAPAWVSAVLVVQWEVARRRAGIGGCSLVTAESWPWFDFSVLKRVPRFAFRPAPSVDGGILVIERRPEPLVRERREYQAFVRQVFTGRGHGLREILQRIGRVQDSDLSAWFRAHGVSPQALPKDLTAEQWASLWGMARGGRSVPRTRRPRGLPPRTSRGPRRNSG	71.94	gnl|BL_ORD_ID|325|hsp_num:0	356			114	219	lincomycin
BGC0000382.1|Lipstatin_14 # 17645 # 18094 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.724	BGC0000382.1|Lipstatin_14 	17645	18094	+	Loose	850	25.409	opmE	34.92	3003700	protein homolog model	n/a	n/a	macrolide antibiotic; carbapenem; tetracycline antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCATTGATCGATTCAGCCTGGGCGGAGCTGAACGGCTCCGACGCGGGCCGCCGGGACCTCTGCCTCGATACCGTCAGCGACGTCCTGGAGACGGGCCGTCTGGCGCAGGACGACGTCGAGCGGACCGTCGGGCGCCTCGCCACCGTCGCGCTCTCCGGCGAGAACCACGCCGTACGGGAGTCCGCGCTGCACGCGGTCTGCACGGCCTCCGCGCACTACGAGCTTCCGTACCGGGTGGTGGAGCCGCTCGCCGCCGGGGCGGACGGCTTCGAACCCCTGCTCCTCGCCTACGTTCTGTCCGTCCTCGGCTCCACTCGTGACCGGGCAGCGCTGCCGGTCGTCGAGCGGTTCCTCCACCACCCCCACCCCGAGGTCCGCCAGGAGGCCTCGGAAGCGCTGACGGACCTGGACCGGCACCGGGAGCCGACCCGGGACACGACGGCGTAG	MALIDSAWAELNGSDAGRRDLCLDTVSDVLETGRLAQDDVERTVGRLATVALSGENHAVRESALHAVCTASAHYELPYRVVEPLAAGADGFEPLLLAYVLSVLGSTRDRAALPVVERFLHHPHPEVRQEASEALTDLDRHREPTRDTTA	MKPYLRSSLSALILLGGCAAVGPDYAPPSASAPASFGAMPAGIDGSGVEIEWWRGFDEPALESLIQRALAANLDIALAGARLDEAKALLRENREEFLPRGGPAFDYQARRRGEVETPAGQQRDIETYRGALDASWEIDLFGRVRRSVEAAEAQAGSREALLRNVQASVAATVAMSWFQLQGIEAELAVVHDIAGNQRDSLEMVERLVSAGSAHEFDRLRAEALLHNVEAAVPDLERRRAATRNALAVLLAEAPQAFSPPVARASGERLTLRTLGVGDPAGLLARRADIAAAERNLAAATARIGVETAGLYPQVEVRGSIGLVAGNLDALDESGTSFNVLNPVIRWALLDRGRVWARIAASEARAQEALILYDRTVLRALQETDDAFNGYGAAADRLRLRLLEATANREAARLARERFVQGDGEYLDVLEAERSDYLSRRALSIARTEQRLAVVGIYKALGGGWEACAGARRCGVATDDTSPGVARQRDSRS	30.35	gnl|BL_ORD_ID|2019|hsp_num:0	2213			555	738	erythromycin; acriflavine; tetracycline; imipenem; trimethoprim; chloramphenicol; thiamphenicol; kitasamycin; rokitamycin
BGC0000382.1|Lipstatin_15 # 18174 # 19400 # -1 # ID=1_15;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.763	BGC0000382.1|Lipstatin_15 	18174	19400	-	Loose	700	58.9214	EreB	23.04	3000363	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide esterase	TTCACCGGGCTTTCAAAGATACGCTTGCGGGACATGATGAGTCAGGACATCCGGGAAATCGTCCCTGCGTCGTGCGCCCTGCTGGGCCTGGGAGAGCCGACGCACCTTGAACCCGCCTTCGGGTGGGTCCGCAACGACCTGTTCGGGCAGCTCGCCGGGATCGGCTTCCGGTCGGTCGCCCTGGAGGTCGACCGAGTGGCCGCGCTCGCCGTCGACGACTACGTCCGCAAGGGGCGGGGGACCCTCGACGCGGTGATGCGCGAGGGGTTCAGCCACGGCTGGGGGGAGTCGGCGGCCAACCGGCGGCTCGTCGCGTGGATGCACGCGTACAACCGGAACCGGCCCCCGCAGGAGCGGCTCGCCTTCCACGGCTTCGACGCGCCGACGGAGTCCATGAGCGCGCCCAGTCCCCGCCCGTACCTGGAGCACGCGCGCGCCCACCTGGGCCTGGACCTCGGCGCGGACCTCGCGGAGCTGGCCGGCGACGACGCGCGGTGGAGCCGCCCGGAGGCGGTCCTGGACGCGGCGGCCTCGCCGGGGGCCGAGCCGGCGACCACGGCGCTGCTGGCGCTCGCCGACGACCTGTGGGGCGCACTGTACGCGCGCGCGCCGGAGCGGATCGCGGCCACGTCACGGGAGGAGTGGCACCGGGCGGGCGTCCACCTCGCCGCGGGGCGCGGTCTGTTGCGCTACCACCGGCAGGCGGCGCGGCCCATGGACCAGCCGGAGCGGGTGCGGGGGCTGCTCGCCGTGCGGGACGGGCTGATGGCGGAGAACCTGCTCGCCATCCGCGCCGCCGAGGCCGGGCGGGGCCCGACGCTGGTCTGCGCGCACAACCTCCACCTCCAGCGGCCGCCGAGCAGCATGCGGCTGGGGGACGCGGACCTCACCTGGTCCGGTGCCGGCGCGGTGGTGGGGGCCCTGCTGGGCGCGGAGTACGCGTTCGTCGCCGGCAGCCTGGGCCGCAGCGCGGCGATCGGCCTGGGCGAGCCGGAGCCGGACACGTACGAGGGGCTGCTGCAGCGGCGGGCGGAGGGCTCAGGGTGGGGGCTGACCGCGGCCCCCGGGGCCGGCTCGGCCCGTACGCGCACCGACACCGTGCCGCAGCAGGGCTATTTCCCCCTCGGGGCGGCGGTCTTGGCGGGCGCGGCAGCGGTCCTCCACATCCCGGACGGCCCGCGGACGACCGCCGGCCACCAGGCCGACGCGGCGACGGCGGCCGGGTAG	FTGLSKIRLRDMMSQDIREIVPASCALLGLGEPTHLEPAFGWVRNDLFGQLAGIGFRSVALEVDRVAALAVDDYVRKGRGTLDAVMREGFSHGWGESAANRRLVAWMHAYNRNRPPQERLAFHGFDAPTESMSAPSPRPYLEHARAHLGLDLGADLAELAGDDARWSRPEAVLDAAASPGAEPATTALLALADDLWGALYARAPERIAATSREEWHRAGVHLAAGRGLLRYHRQAARPMDQPERVRGLLAVRDGLMAENLLAIRAAEAGRGPTLVCAHNLHLQRPPSSMRLGDADLTWSGAGAVVGALLGAEYAFVAGSLGRSAAIGLGEPEPDTYEGLLQRRAEGSGWGLTAAPGAGSARTRTDTVPQQGYFPLGAAVLAGAAAVLHIPDGPRTTAGHQADAATAAG	MRFEEWVKDKHIPFKLNHPDDNYDDFKPLRKIIGDTRVVALGENSHFIKEFFLLRHTLLRFFIEDLGFTTFAFEFGFAEGQIINNWIHGQGTDDEIGRFLKHFYYPEELKTTFLWLREYNKAAKEKITFLGIDIPRNGGSYLPNMEIVHDFFRTADKEALHIIDDAFNIAKKIDYFSTSQAALNLHELTDSEKCRLTSQLARVKVRLEAMAPIHIEKYGIDKYETILHYANGMIYLDYNIQAMSGFISGGGMQGDMGAKDKYMADSVLWHLKNPQSEQKVIVVAHNAHIQKTPILYDGFLSCLPMGQRLKNAIGDDYMSLGITSYSGHTAALYPEVDTKYGFRVDNFQLQEPNEGSVEKAISGCGVTNSFVFFRNIPEDLQSIPNMIRFDSIYMKAELEKAFDGIFQIEKSSVSEVVYE	97.37	gnl|BL_ORD_ID|1771|hsp_num:0	1921			84	1134	erythromycin; roxithromycin; clarithromycin; azithromycin
